[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Novabridge Biosciences ADR (NBP)

Novabridge Biosciences ADR (NBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 212,794
  • Shares Outstanding, K 115,649
  • Annual Sales, $ 0 K
  • Annual Income, $ -46,270 K
  • EBIT $ -40 M
  • EBITDA $ -39 M
  • 60-Month Beta 1.47
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.09

Options Overview Details

View History
  • Implied Volatility 565.86% (+402.33%)
  • Historical Volatility 49.62%
  • IV Percentile 70%
  • IV Rank 38.41%
  • IV High 1,416.83% on 07/14/26
  • IV Low 35.23% on 07/23/26
  • Expected Move (DTE 17) 0.0000 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 370
  • Volume Avg (30-Day) 212
  • Put/Call OI Ratio 0.02
  • Today's Open Interest 2,087
  • Open Int (30-Day) 1,914
  • Expected Range 1.8200 to 1.8200

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.14
  • Number of Estimates 1
  • High Estimate $-0.14
  • Low Estimate $-0.14
  • Prior Year $-0.07
  • Growth Rate Est. (year over year) -100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5850 +14.83%
on 08/03/26
2.0200 -9.90%
on 08/21/26
+0.2200 (+13.75%)
since 07/31/26
3-Month
1.4600 +24.66%
on 06/15/26
2.2697 -19.81%
on 07/02/26
-0.0200 (-1.09%)
since 05/29/26
52-Week
1.4600 +24.66%
on 06/15/26
6.7900 -73.20%
on 10/16/25
-2.4300 (-57.18%)
since 08/28/25

Most Recent Stories

More News
NovaBridge Biosciences to Participate in September Investor Conferences

ROCKVILLE, Md., Aug. 27, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a global biotechnology company that identifies differentiated innovation...

NBP : 1.8200 (-1.09%)
NovaBridge Biosciences to Participate in September Investor Conferences

ROCKVILLE, Md., Aug. 27, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a global biotechnology company...

NBP : 1.8200 (-1.09%)
NovaBridge Reports First Half 2026 Financial Results and Highlights Pipeline Momentum and Strategic Execution

Executing NovaBridge’s strategy to identify differentiated science, develop it efficiently and create long-term value for patients and shareholders Appointed Srishti Gupta, MD, MPP, as Chief Executive...

NBP : 1.8200 (-1.09%)
NovaBridge Reports First Half 2026 Financial Results and Highlights Pipeline Momentum and Strategic Execution

ROCKVILLE, Md., Aug. 20, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a global biotechnology company that identifies differentiated innovation...

NBP : 1.8200 (-1.09%)
NovaBridge to Report First Half 2026 Financial Results and Provide a Corporate Update on Thursday, August 20, 2026

ROCKVILLE, Md., Aug. 13, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a global biotechnology company that identifies differentiated innovation...

NBP : 1.8200 (-1.09%)
NovaBridge to Report First Half 2026 Financial Results and Provide a Corporate Update on Thursday, August 20, 2026

ROCKVILLE, Md., Aug. 13, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a global biotechnology company that identifies differentiated innovation...

NBP : 1.8200 (-1.09%)
NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026

ROCKVILLE, Md., July 24, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines...

TWR.AX : 1.510 (-1.95%)
NBP : 1.8200 (-1.09%)
NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026

ROCKVILLE, Md., July 24, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines...

NBP : 1.8200 (-1.09%)
NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer

ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines...

IVVD : 0.9549 (-1.00%)
NBP : 1.8200 (-1.09%)
NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer

ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage...

NBP : 1.8200 (-1.09%)

Business Summary

NovaBridge Biosciences is a biotechnology platform company committed to accelerating access to innovative medicines. NovaBridge Biosciences, formerly known as I-MAB, is based in ROCKVILLE, Md.

See More

Key Turning Points

3rd Resistance Point 1.9217
2nd Resistance Point 1.8933
1st Resistance Point 1.8567
Last Price 1.8200
1st Support Level 1.7917
2nd Support Level 1.7633
3rd Support Level 1.7267

See More

52-Week High 6.7900
Fibonacci 61.8% 4.7539
Fibonacci 50% 4.1250
Fibonacci 38.2% 3.4961
Last Price 1.8200
52-Week Low 1.4600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.